Status:
COMPLETED
Evaluation of Articaine 4% Versus Mepivacaine 2% for Surgery of Molars Thirds: Clinical Trial.
Lead Sponsor:
Universidade Estadual Paulista Júlio de Mesquita Filho
Collaborating Sponsors:
Prof. Dr. Fernando Vagner Raldi
Paula Carolina de Almeida
Conditions:
Pain
Teeth, Impacted
Eligibility:
All Genders
16-40 years
Phase:
NA
Brief Summary
The extraction of third molars, a frequent treatment in clinical dental practice, can lead patients to painful symptoms during and after surgery. The dental surgeon must correctly indicate the need fo...
Detailed Description
This study will compare the use of Articaine at 4% to that of Mepivacaine at 2% for lower third molar surgeries semi-included and / or included. I will select 16 patients who require surgical treatmen...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists Classification -(ASA I) patients;
- Patients with need for extraction of lower third molars included and / or semi-included;
- Teeth in opposing hemiarch with the same classifications as Pell and Gregory and Winter;
- Age between 16 and 40 years;
- Patients who agree to voluntarily participate in the survey.
Exclusion
- History of allergic reactions (hypersensitivity) to anesthetics;
- Patients presenting with local or systemic alterations that contraindicate the procedure;
- Current use of drugs that may interfere with the action of anesthetics;
- Need for sedatives or anxiolytic drugs during extraction;
- Pregnancy or breastfeeding;
- Third erupted lower third molars.
Key Trial Info
Start Date :
December 7 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 4 2018
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT03384160
Start Date
December 7 2017
End Date
December 4 2018
Last Update
February 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michelle Bianchi de Moraes
São José dos Campos, São Paulo, Brazil, 12245000